Free Trial
NASDAQ:NOTV

Inotiv (NOTV) Stock Price, News & Analysis

Inotiv logo
$3.80 -0.22 (-5.47%)
(As of 12/6/2024 ET)

About Inotiv Stock (NASDAQ:NOTV)

Key Stats

Today's Range
$3.75
$4.20
50-Day Range
$1.58
$4.19
52-Week Range
$1.23
$11.42
Volume
817,647 shs
Average Volume
367,906 shs
Market Capitalization
$98.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.92
Consensus Rating
Moderate Buy

Company Overview

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Inotiv Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
52nd Percentile Overall Score

NOTV MarketRank™: 

Inotiv scored higher than 52% of companies evaluated by MarketBeat, and ranked 565th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inotiv has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Inotiv has only been the subject of 1 research reports in the past 90 days.

  • Read more about Inotiv's stock forecast and price target.
  • Earnings Growth

    Earnings for Inotiv are expected to grow by 675.00% in the coming year, from $0.04 to $0.31 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Inotiv is -0.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Inotiv is -0.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Inotiv has a P/B Ratio of 0.37. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.64% of the float of Inotiv has been sold short.
  • Short Interest Ratio / Days to Cover

    Inotiv has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Inotiv has recently increased by 13.95%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Inotiv does not currently pay a dividend.

  • Dividend Growth

    Inotiv does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.64% of the float of Inotiv has been sold short.
  • Short Interest Ratio / Days to Cover

    Inotiv has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Inotiv has recently increased by 13.95%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Inotiv has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Inotiv this week, compared to 1 article on an average week.
  • Search Interest

    9 people have searched for NOTV on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inotiv insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.80% of the stock of Inotiv is held by insiders.

  • Percentage Held by Institutions

    Only 18.17% of the stock of Inotiv is held by institutions.

  • Read more about Inotiv's insider trading history.
Receive NOTV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inotiv and its competitors with MarketBeat's FREE daily newsletter.

NOTV Stock News Headlines

Lake Street Sticks to Its Buy Rating for Inotiv (NOTV)
Inotiv, Inc. Announces Fiscal Year 2024 Results
We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Inotiv, Inc. (NOTV) Q4 2024 Earnings Call Transcript
Uncovering Potential: Inotiv's Earnings Preview
See More Headlines

NOTV Stock Analysis - Frequently Asked Questions

Inotiv's stock was trading at $3.67 at the beginning of the year. Since then, NOTV stock has increased by 3.5% and is now trading at $3.80.
View the best growth stocks for 2024 here
.

Inotiv, Inc. (NASDAQ:NOTV) issued its quarterly earnings data on Thursday, December, 16th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.10. The company had revenue of $30.08 million for the quarter. Inotiv had a negative net margin of 22.10% and a negative trailing twelve-month return on equity of 15.05%.

Top institutional shareholders of Inotiv include Geode Capital Management LLC (0.96%), Thurston Springer Miller Herd & Titak Inc. (0.07%) and Wolverine Trading LLC. Insiders that own company stock include John E Sagartz, John Gregory Beattie, William D Pitchford, R Matthew Neff, Michael Garrett, Robert Jr Leasure, James Harkness, Gregory Cole Davis and Philip A Downing.
View institutional ownership trends
.

Shares of NOTV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inotiv investors own include NVIDIA (NVDA), Arista Networks (ANET), Alibaba Group (BABA), Meta Platforms (META), Super Micro Computer (SMCI), Weatherford International (WFRD) and Axcelis Technologies (ACLS).

Company Calendar

Last Earnings
12/16/2021
Today
12/06/2024
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
Business Services
Current Symbol
NASDAQ:NOTV
Employees
2,055
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.92
High Stock Price Target
$10.00
Low Stock Price Target
$3.75
Potential Upside/Downside
+55.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-105,140,000.00
Pretax Margin
-22.74%

Debt

Sales & Book Value

Annual Sales
$490.74 million
Cash Flow
$0.39 per share
Book Value
$10.41 per share

Miscellaneous

Free Float
24,496,000
Market Cap
$98.82 million
Optionable
Optionable
Beta
3.62
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:NOTV) was last updated on 12/6/2024 by MarketBeat.com Staff
From Our Partners